Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Cross FH"'
Publikováno v:
The Journal of laryngology and otology. 82(6)
Autor:
Coroller T; Novartis Pharmaceutical Company, East Hanover, New Jersey, USA., Sahiner B; Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Amatya A; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Gossmann A; Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Karagiannis K; Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Moloney C; Novartis Pharma AG, Rotkreuz, Switzerland., Samala RK; Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Santana-Quintero L; Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Solovieff N; Novartis Pharmaceutical Company, East Hanover, New Jersey, USA., Wang C; Novartis Pharma AG, Rotkreuz, Switzerland., Amiri-Kordestani L; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Cao Q; Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Cha KH; Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Charlab R; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Cross FH Jr; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Hu T; Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Huang R; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Kraft J; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Krusche P; Novartis Pharma AG, Rotkreuz, Switzerland., Li Y; Novartis Pharmaceutical Company, East Hanover, New Jersey, USA., Li Z; Novartis Pharmaceutical Company, East Hanover, New Jersey, USA., Mazo I; Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Paul R; Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Schnakenberg S; Novartis Pharmaceutical Company, East Hanover, New Jersey, USA., Serra P; Novartis Pharmaceutical Company, East Hanover, New Jersey, USA., Smith S; Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Song C; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Su F; Novartis Pharmaceutical Company, East Hanover, New Jersey, USA., Tiwari M; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Vechery C; Novartis Pharmaceutical Company, East Hanover, New Jersey, USA., Xiong X; Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Zarate JP; Novartis Pharmaceutical Company, East Hanover, New Jersey, USA., Zhu H; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Chakravartty A; Novartis Pharmaceutical Company, East Hanover, New Jersey, USA., Liu Q; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Ohlssen D; Novartis Pharmaceutical Company, East Hanover, New Jersey, USA., Petrick N; Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Schneider JA; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Walderhaug M; Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Zuber E; Novartis Pharma AG, Rotkreuz, Switzerland.
Publikováno v:
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2024 Apr; Vol. 115 (4), pp. 745-757. Date of Electronic Publication: 2024 Jan 31.
Publikováno v:
American journal of veterinary research [Am J Vet Res] 1978 Mar; Vol. 39 (3), pp. 399-405.
Publikováno v:
American journal of veterinary research [Am J Vet Res] 1978 Mar; Vol. 39 (3), pp. 433-40.
Publikováno v:
Radiation research [Radiat Res] 1976 Jun; Vol. 66 (3), pp. 626-33.
Publikováno v:
American journal of veterinary research [Am J Vet Res] 1979 Mar; Vol. 40 (3), pp. 377-83.
Publikováno v:
Irish medical journal [Ir Med J] 1981 Feb; Vol. 74 (2), pp. 57-8.
Publikováno v:
Radiation research [Radiat Res] 1961 Nov; Vol. 15, pp. 675-83.
Publikováno v:
American journal of veterinary research [Am J Vet Res] 1969 Nov; Vol. 30 (11), pp. 1921-7.
Publikováno v:
Radiation research [Radiat Res] 1965 Jul; Vol. 25, pp. 574-85.